ACERCA DE ESTE EPISODIO
Our hosts, Dr. Amir Kalali, Craig Lipset, and Jane Myles were joined by Owen Muir (Radial) to share insights from Beijing from the Life Sciences Technology Forum earlier this year. Notes on what they saw, heard, and learned about the rapidly evolving life sciences landscape in China were shared.
The conversation explores the speed and scale of technology adoption, China's growing sophistication in drug development and clinical research, and some eye-opening examples from neuromodulation and healthcare delivery. They also discuss what it takes to conduct global trials across markets, where the U.S. and China approach innovation differently, and why collaboration on shared challenges may be just as important as competition.
Their takeaway: China is increasingly important to the future of global drug development—and understanding what's happening there firsthand matters.
Follow the Digital Trials & Research Alliance (DTRA) on LinkedIn and X. Learn more about Membership options and our work at www.dtra.org.
